IRVINE, Calif. – August 9, 2023 – Diality Inc., a medical technology company developing a user friendly, mobile and connected hemodialysis system with a category leading prescription range, today announced the closing of a $28 million investment round. The funding will be used to support Diality’s 510(k) filing and pre-commercialization activities through initial commercial launch targeting hospitals, skilled nursing facilities, and de novo clinics. The funding will also support initiation and early enrollment of Diality’s U.S. home hemodialysis clinical trial. Read the full press release here.

IRVINE, Calif. – May 31, 2023 – Diality Inc., a medical technology company developing a smart, flexible hemodialysis platform, today announced the appointment of healthcare veteran Robert Funari to its board of directors. Funari has spent nearly 50 years in the healthcare industry in public and privately held companies, in both services and medical devices. Read the full press release here.

IRVINE, Calif., Sept 15, 2022 /BUSINESS WIRE/ -- Diality Inc., a medical technology company developing a smart, mobile hemodialysis platform, today announced the hiring of Pamela Wapnick as chief financial officer. She brings to the company more than 30 years of highly diversified financial experience, primarily in the biotech and pharmaceutical industries, as it readies for the commercial launch of its technology in 2023. Read the full press release here.

IRVINE, Calif., June 29, 2022 -- Diality, Inc. has announced that it has joined the Innovative Kidney Care (IKC) campaign… Read the full press release here.

IRVINE, Calif., March 28, 2022 /PRNewswire/ -- Medical device startup, Diality, Inc. announced it had reached an agreement and partnership with Paramit Corporation for the upcoming manufacture of Diality's versatile hemodialysis system… Read the full press release here.

IRVINE, Calif., March 2, 2022 /PRNewswire/ -- Diality, Inc., a medical device company that is developing a versatile hemodialysis system to address the unmet technology needs of the evolving dialysis industry, announced the close of a $24 million Series B2 investment round… Read the full press release here.

‍

IRVINE, Calif., Aug. 30, 2021 /PRNewswire/ -- Diality Inc. officially announced the addition of Dr. Nissenson to its board of directors. A widely acknowledged expert in kidney disease, Dr. Nissenson is Emeritus Professor of Medicine at the David Geffen School of Medicine at UCLA where he also served as both associate dean and the director of the dialysis program. He was Chief Medical Officer for DaVita Kidney Care for over 11 years and now serves as emeritus chief medical officer... Read the full press release here.

IRVINE, Calif., July 6, 2021 /PRNewswire/ -- Medical device startup Diality announced Dan Guthrie would become the newest member of its executive team, serving as Chief Business Officer effective July 1... Read the full press release here.